Ultrathin-strut Biodegradable Polymer Sirolimus-eluting Stent
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ultrathin-strut Biodegradable Polymer Sirolimus-eluting Stent, covering 2025-12-16 to 2025-12-16. Get the full timeline:
Most recent: Clinical Trial Update: Ultrathin-strut Biodegradable Polymer Sirolimus-eluting Stents With P2Y12 Inhibitor-based Single Antiplatelet Therapy vs. Conventional DAPT for Unprotected Left Main Coronary Artery Disease (ULTIMATE-LM) [NA]